Promising bactericidal approach of dihydrazone analogues against bio-film forming Gram-negative bacteria and molecular mechanistic studies

Gram-negative members of the ESCAPE family are more difficult to treat, due to the presence of an additional barrier in the form of a lipopolysaccharide layer and the efficiency of efflux pumps to pump out the drugs from the cytoplasm. The development of alternative therapeutic strategies to tackle...

Full description

Saved in:
Bibliographic Details
Published inRSC advances Vol. 8; no. 10; pp. 5473 - 5483
Main Authors Rakesh, K P, Vivek, H K, Manukumar, H M, Shantharam, C S, Bukhari, S N A, Qin, Hua-Li, Sridhara, M B
Format Journal Article
LanguageEnglish
Published England Royal Society of Chemistry 01.01.2018
The Royal Society of Chemistry
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Gram-negative members of the ESCAPE family are more difficult to treat, due to the presence of an additional barrier in the form of a lipopolysaccharide layer and the efficiency of efflux pumps to pump out the drugs from the cytoplasm. The development of alternative therapeutic strategies to tackle ESCAPE Gram-negative members is of extreme necessity to provide a solution to the cause of life-threatening infections. The present investigations demonstrated that compounds 17, 20, 25 and 26 possessing the presence of electron donating (OH and OCH ) groups on the phenyl rings are highly potent; whereas compounds 9, 10, 15, 16, 18, 33 and 36 showed moderate activity against Gram-negative bacteria. An excellent dose-dependent antibacterial activity was established compared to that of the standard antibiotic ampicillin. Significant anti-biofilm properties were measured quantitatively, showing optical density (O.D) values of 0.51 ± 015, 0.63 ± 0.20, 0.38 ± 0.07 and 0.62 ± 0.11 at 492 nm and the leakage of cellular components by the compounds, such as 17, 20, 25 and 26, increased the O.D. of respective treated samples compared to the control. In addition, the implication of experimental results is discussed in the light of the lack of survivability of planktonic bacteria and biofilm destruction . These results revealed the great significance of the development of a new generation of synthetic materials with greater efficacy in anti-biofilm properties by targeting to lock the bio-film associated protein Bap in Gram-negative bacteria.
AbstractList Gram-negative members of the ESCAPE family are more difficult to treat, due to the presence of an additional barrier in the form of a lipopolysaccharide layer and the efficiency of efflux pumps to pump out the drugs from the cytoplasm. The development of alternative therapeutic strategies to tackle ESCAPE Gram-negative members is of extreme necessity to provide a solution to the cause of life-threatening infections. The present investigations demonstrated that compounds 17, 20, 25 and 26 possessing the presence of electron donating (OH and OCH ) groups on the phenyl rings are highly potent; whereas compounds 9, 10, 15, 16, 18, 33 and 36 showed moderate activity against Gram-negative bacteria. An excellent dose-dependent antibacterial activity was established compared to that of the standard antibiotic ampicillin. Significant anti-biofilm properties were measured quantitatively, showing optical density (O.D) values of 0.51 ± 015, 0.63 ± 0.20, 0.38 ± 0.07 and 0.62 ± 0.11 at 492 nm and the leakage of cellular components by the compounds, such as 17, 20, 25 and 26, increased the O.D. of respective treated samples compared to the control. In addition, the implication of experimental results is discussed in the light of the lack of survivability of planktonic bacteria and biofilm destruction . These results revealed the great significance of the development of a new generation of synthetic materials with greater efficacy in anti-biofilm properties by targeting to lock the bio-film associated protein Bap in Gram-negative bacteria.
Gram-negative members of the ESCAPE family are more difficult to treat, due to the presence of an additional barrier in the form of a lipopolysaccharide layer and the efficiency of efflux pumps to pump out the drugs from the cytoplasm. The development of alternative therapeutic strategies to tackle ESCAPE Gram-negative members is of extreme necessity to provide a solution to the cause of life-threatening infections. The present investigations demonstrated that compounds 17 , 20 , 25 and 26 possessing the presence of electron donating (OH and OCH 3 ) groups on the phenyl rings are highly potent; whereas compounds 9 , 10 , 15 , 16 , 18 , 33 and 36 showed moderate activity against Gram-negative bacteria. An excellent dose-dependent antibacterial activity was established compared to that of the standard antibiotic ampicillin. Significant anti-biofilm properties were measured quantitatively, showing optical density (O.D) values of 0.51 ± 015, 0.63 ± 0.20, 0.38 ± 0.07 and 0.62 ± 0.11 at 492 nm and the leakage of cellular components by the compounds, such as 17 , 20 , 25 and 26 , increased the O.D. of respective treated samples compared to the control. In addition, the implication of experimental results is discussed in the light of the lack of survivability of planktonic bacteria and biofilm destruction in vitro . These results revealed the great significance of the development of a new generation of synthetic materials with greater efficacy in anti-biofilm properties by targeting to lock the bio-film associated protein Bap in Gram-negative bacteria.
Gram-negative members of the ESCAPE family are more difficult to treat, due to the presence of an additional barrier in the form of a lipopolysaccharide layer and the efficiency of efflux pumps to pump out the drugs from the cytoplasm. The development of alternative therapeutic strategies to tackle ESCAPE Gram-negative members is of extreme necessity to provide a solution to the cause of life-threatening infections. The present investigations demonstrated that compounds 17, 20, 25 and 26 possessing the presence of electron donating (OH and OCH 3 ) groups on the phenyl rings are highly potent; whereas compounds 9, 10, 15, 16, 18, 33 and 36 showed moderate activity against Gram-negative bacteria. An excellent dose-dependent antibacterial activity was established compared to that of the standard antibiotic ampicillin. Significant anti-biofilm properties were measured quantitatively, showing optical density (O.D) values of 0.51 ± 015, 0.63 ± 0.20, 0.38 ± 0.07 and 0.62 ± 0.11 at 492 nm and the leakage of cellular components by the compounds, such as 17, 20, 25 and 26, increased the O.D. of respective treated samples compared to the control. In addition, the implication of experimental results is discussed in the light of the lack of survivability of planktonic bacteria and biofilm destruction in vitro . These results revealed the great significance of the development of a new generation of synthetic materials with greater efficacy in anti-biofilm properties by targeting to lock the bio-film associated protein Bap in Gram-negative bacteria. Gram-negative members of the ESCAPE family are more difficult to treat, due to the presence of an additional barrier in the form of a lipopolysaccharide layer and the efficiency of efflux pumps to pump out the drugs from the cytoplasm.
Gram-negative members of the ESCAPE family are more difficult to treat, due to the presence of an additional barrier in the form of a lipopolysaccharide layer and the efficiency of efflux pumps to pump out the drugs from the cytoplasm. The development of alternative therapeutic strategies to tackle ESCAPE Gram-negative members is of extreme necessity to provide a solution to the cause of life-threatening infections. The present investigations demonstrated that compounds 17, 20, 25 and 26 possessing the presence of electron donating (OH and OCH3) groups on the phenyl rings are highly potent; whereas compounds 9, 10, 15, 16, 18, 33 and 36 showed moderate activity against Gram-negative bacteria. An excellent dose-dependent antibacterial activity was established compared to that of the standard antibiotic ampicillin. Significant anti-biofilm properties were measured quantitatively, showing optical density (O.D) values of 0.51 ± 015, 0.63 ± 0.20, 0.38 ± 0.07 and 0.62 ± 0.11 at 492 nm and the leakage of cellular components by the compounds, such as 17, 20, 25 and 26, increased the O.D. of respective treated samples compared to the control. In addition, the implication of experimental results is discussed in the light of the lack of survivability of planktonic bacteria and biofilm destruction in vitro. These results revealed the great significance of the development of a new generation of synthetic materials with greater efficacy in anti-biofilm properties by targeting to lock the bio-film associated protein Bap in Gram-negative bacteria.
Author Sridhara, M B
Shantharam, C S
Manukumar, H M
Vivek, H K
Bukhari, S N A
Qin, Hua-Li
Rakesh, K P
Author_xml – sequence: 1
  givenname: K P
  orcidid: 0000-0001-9317-8462
  surname: Rakesh
  fullname: Rakesh, K P
  email: qinhuali@whut.edu.cn
  organization: Department of Pharmaceutical Engineering, School of Chemistry, Chemical Engineering and Life Science, Wuhan University of Technology 205 Luoshi Road Wuhan 430073 PR China qinhuali@whut.edu.cn +86 27 87749300
– sequence: 2
  givenname: H K
  orcidid: 0000-0002-5808-5583
  surname: Vivek
  fullname: Vivek, H K
  organization: Analytical Research and Development, Syngene International Ltd Biocon Park, Bommasandra Industrial Estate Bangaluru-560099 Karnataka India
– sequence: 3
  givenname: H M
  orcidid: 0000-0002-6488-7136
  surname: Manukumar
  fullname: Manukumar, H M
  organization: Department of Studies in Biotechnology, University of Mysore Manasagangotri Mysuru-570006 Karnataka India
– sequence: 4
  givenname: C S
  orcidid: 0000-0002-1021-0584
  surname: Shantharam
  fullname: Shantharam, C S
  organization: Department of Chemistry, Pooja Bhagavath Memorial Mahajana Education Centre Mysuru-570016 Karnataka India
– sequence: 5
  givenname: S N A
  orcidid: 0000-0001-8125-7972
  surname: Bukhari
  fullname: Bukhari, S N A
  email: qinhuali@whut.edu.cn
  organization: Department of Pharmaceutical Engineering, School of Chemistry, Chemical Engineering and Life Science, Wuhan University of Technology 205 Luoshi Road Wuhan 430073 PR China qinhuali@whut.edu.cn +86 27 87749300
– sequence: 6
  givenname: Hua-Li
  surname: Qin
  fullname: Qin, Hua-Li
  email: qinhuali@whut.edu.cn
  organization: Department of Pharmaceutical Engineering, School of Chemistry, Chemical Engineering and Life Science, Wuhan University of Technology 205 Luoshi Road Wuhan 430073 PR China qinhuali@whut.edu.cn +86 27 87749300
– sequence: 7
  givenname: M B
  surname: Sridhara
  fullname: Sridhara, M B
  email: sridhara.mb@gmail.com
  organization: Department of Chemistry, Rani Channamma University Vidyasangama Belagavi-591156 Karnataka India sridhara.mb@gmail.com +91 9663983459
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35542417$$D View this record in MEDLINE/PubMed
BookMark eNpdkdtqFTEUhoNUbN32xgeQgDdFGM1hJpncCGWjW6GgiF6HNTnMTplJtslMoT6CT21qD1RzswL51r9W_v85OoopOoReUvKWEq7eGZmBciHo-ASdMNKKhhGhjh7dj9FpKZekHtFRJugzdMy7rmUtlSfo99ec5lBCHPEAZnE5mGBhwnA45ARmj5PHNuyvbYZfdTCGCFMaV1cwjBBiWfAQUuPDNGOf8nyjs8swN9GNsIQrd68KtdPiOU3OrBNkPDuzhxjKEgwuy2qDKy_QUw9Tcad3dYN-fPzwffupufiy-7w9v2hMS8TSiF60XDlgtPOgvJGks4xy1Zre0U5RxrinrPey_tAIwb2zreyHgVjHrWx7vkHvb3UP6zA7a1xcMkz6kMMM-VonCPrflxj2ekxXWhHZU8KqwNmdQE4_qxWLrg4aN00QXVqLZkKwrlWSdhV9_R96mdZcPawUoaRXRNQUN-jNLWVyKiU7_7AMJfomZb2V387_pryr8KvH6z-g95nyP0Lspt4
CitedBy_id crossref_primary_10_1039_C8RA02903B
crossref_primary_10_1016_j_ejmech_2020_113134
crossref_primary_10_1016_j_micpath_2020_104499
crossref_primary_10_1016_j_molstruc_2021_130953
crossref_primary_10_1016_j_ejmcr_2021_100015
crossref_primary_10_1016_j_ejmech_2018_11_031
crossref_primary_10_1016_j_ejmech_2023_116072
crossref_primary_10_1155_2024_9941516
crossref_primary_10_1016_j_procbio_2023_10_024
crossref_primary_10_1038_s41598_019_44304_1
crossref_primary_10_1039_C9RA03380G
crossref_primary_10_1016_j_bioorg_2020_103885
crossref_primary_10_1016_j_bioorg_2020_104316
crossref_primary_10_1016_j_micpath_2019_03_002
crossref_primary_10_1093_jambio_lxae104
crossref_primary_10_1007_s11164_020_04359_6
crossref_primary_10_1016_j_ejmech_2020_112832
crossref_primary_10_1016_j_micpath_2018_07_025
crossref_primary_10_1002_ardp_202100266
crossref_primary_10_1016_j_ejmech_2021_113442
crossref_primary_10_1016_j_ijbiomac_2021_01_190
crossref_primary_10_1186_s13065_023_00958_7
crossref_primary_10_1016_j_bioorg_2019_103093
crossref_primary_10_1016_j_ejmech_2020_113069
crossref_primary_10_2174_1871520620666200225104558
crossref_primary_10_1016_j_ejmech_2020_112892
crossref_primary_10_1016_j_rechem_2023_101151
crossref_primary_10_1016_j_bioorg_2019_103133
crossref_primary_10_1039_D0RA05319H
crossref_primary_10_1016_j_biopha_2022_113302
crossref_primary_10_2174_1570180819666220317151208
crossref_primary_10_1016_j_rechem_2020_100067
crossref_primary_10_3390_pr12061055
crossref_primary_10_1016_j_bmcl_2019_02_003
crossref_primary_10_1002_ardp_202000223
crossref_primary_10_1016_j_bioorg_2021_105116
crossref_primary_10_1016_j_cdc_2019_100193
crossref_primary_10_1007_s00044_020_02549_w
crossref_primary_10_1016_j_ejmech_2020_112245
crossref_primary_10_1016_j_biocel_2019_105566
crossref_primary_10_1002_ardp_202000165
Cites_doi 10.4161/viru.2.5.17724
10.1039/C7MD00486A
10.1016/j.arabjc.2017.09.017
10.1016/j.bmcl.2017.05.032
10.1016/j.bioorg.2016.07.001
10.1128/CMR.15.2.167-193.2002
10.3390/medicines4020025
10.1016/S1473-3099(11)70316-4
10.1016/j.foodcont.2011.11.030
10.1186/s13613-015-0061-0
10.1039/C6RA23374K
10.1515/hc-2013-0035
10.1038/nrmicro2319
10.1038/srep18877
10.1039/C7MD00111H
10.3390/medicina47030019
10.1086/595011
10.1038/ja.2014.142
10.1016/j.bmcl.2015.01.010
10.1039/C7MD00209B
10.1111/j.1469-0691.2011.03570.x
10.1016/j.addr.2005.04.002
10.1586/eri.13.12
10.1016/S0140-6736(01)05321-1
10.1016/j.jconrel.2011.07.002
10.1038/nrmicro3155
10.1007/s00044-017-1878-x
10.1038/s41598-017-11597-z
10.1038/nrmicro2415
ContentType Journal Article
Copyright This journal is © The Royal Society of Chemistry.
Copyright Royal Society of Chemistry 2018
This journal is © The Royal Society of Chemistry 2018 The Royal Society of Chemistry
Copyright_xml – notice: This journal is © The Royal Society of Chemistry.
– notice: Copyright Royal Society of Chemistry 2018
– notice: This journal is © The Royal Society of Chemistry 2018 The Royal Society of Chemistry
DBID NPM
AAYXX
CITATION
7SR
8BQ
8FD
JG9
7X8
5PM
DOI 10.1039/c7ra13661g
DatabaseName PubMed
CrossRef
Engineered Materials Abstracts
METADEX
Technology Research Database
Materials Research Database
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle PubMed
CrossRef
Materials Research Database
Engineered Materials Abstracts
Technology Research Database
METADEX
MEDLINE - Academic
DatabaseTitleList PubMed
CrossRef

Materials Research Database
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
EISSN 2046-2069
EndPage 5483
ExternalDocumentID 10_1039_C7RA13661G
35542417
Genre Journal Article
GrantInformation_xml – fundername: ;
  grantid: Unassigned
GroupedDBID -JG
0-7
0R~
53G
AAFWJ
AAHBH
AAIWI
AAJAE
AARTK
AAWGC
AAXHV
ABEMK
ABGFH
ABPDG
ABXOH
ACGFS
ADBBV
ADMRA
AEFDR
AENEX
AESAV
AFLYV
AFPKN
AFVBQ
AGEGJ
AGRSR
AGSTE
AHGCF
AKBGW
ALMA_UNASSIGNED_HOLDINGS
ANUXI
APEMP
ASKNT
AUDPV
BCNDV
BLAPV
BSQNT
C6K
EBS
EE0
EF-
EJD
GROUPED_DOAJ
H13
HZ~
H~N
J3I
M~E
NPM
O9-
OK1
PGMZT
R7C
R7G
RCNCU
RPM
RPMJG
RRC
RSCEA
RVUXY
SLH
SMJ
ZCN
AAEMU
AAYXX
ABASK
AETIL
ANBJS
AUNWK
CITATION
ECGLT
J3G
J3H
RAOCF
ROYLF
YAE
7SR
8BQ
8FD
JG9
7X8
5PM
ID FETCH-LOGICAL-c406t-686439ea215fa9fc705d21394c8e1591223f128f7424c663fed478bb0de3d7483
IEDL.DBID RPM
ISSN 2046-2069
IngestDate Tue Sep 17 21:21:39 EDT 2024
Sat Aug 17 00:53:45 EDT 2024
Fri Sep 13 07:24:43 EDT 2024
Fri Aug 23 02:35:47 EDT 2024
Sat Sep 28 08:21:17 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 10
Language English
License This journal is © The Royal Society of Chemistry.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c406t-686439ea215fa9fc705d21394c8e1591223f128f7424c663fed478bb0de3d7483
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-5808-5583
0000-0001-8125-7972
0000-0002-1021-0584
0000-0002-6488-7136
0000-0001-9317-8462
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9078102/
PMID 35542417
PQID 2010890610
PQPubID 2047525
PageCount 11
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_9078102
proquest_miscellaneous_2662549715
proquest_journals_2010890610
crossref_primary_10_1039_C7RA13661G
pubmed_primary_35542417
PublicationCentury 2000
PublicationDate 2018-01-01
PublicationDateYYYYMMDD 2018-01-01
PublicationDate_xml – month: 01
  year: 2018
  text: 2018-01-01
  day: 01
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: Cambridge
PublicationTitle RSC advances
PublicationTitleAlternate RSC Adv
PublicationYear 2018
Publisher Royal Society of Chemistry
The Royal Society of Chemistry
Publisher_xml – name: Royal Society of Chemistry
– name: The Royal Society of Chemistry
References Lewis (C7RA13661G-(cit13)/*[position()=1]) 2005; 70
Mace (C7RA13661G-(cit27)/*[position()=1]) 2017; 4
Manukumar (C7RA13661G-(cit22)/*[position()=1]) 2017; 7
Mohammad (C7RA13661G-(cit1)/*[position()=1]) 2015; 68
Huh (C7RA13661G-(cit26)/*[position()=1]) 2011; 156
Flemming (C7RA13661G-(cit12)/*[position()=1]) 2010; 8
Da Silva Meira (C7RA13661G-(cit29)/*[position()=1]) 2012; 25
Rakesh (C7RA13661G-(cit14)/*[position()=1]) 2015; 25
Giedraitienė (C7RA13661G-(cit7)/*[position()=1]) 2011; 47
Wang (C7RA13661G-(cit18)/*[position()=1]) 2017; 8
Rakesh (C7RA13661G-(cit15)/*[position()=1]) 2016; 6
Rakesh (C7RA13661G-(cit17)/*[position()=1]) 2017; 26
Rakesh (C7RA13661G-(cit20)/*[position()=1]) 2015; 6
Rakesh (C7RA13661G-(cit16)/*[position()=1]) 2016; 68
Wilson (C7RA13661G-(cit8)/*[position()=1]) 2014; 12
Zha (C7RA13661G-(cit31)/*[position()=1]) 2017; 27
Stewart (C7RA13661G-(cit10)/*[position()=1]) 2001; 358
Donlan (C7RA13661G-(cit11)/*[position()=1]) 2002; 15
Mu (C7RA13661G-(cit30)/*[position()=1]) 2016; 6
Akbar (C7RA13661G-(cit21)/*[position()=1]) 2013; 19
Piddock (C7RA13661G-(cit3)/*[position()=1]) 2012; 12
Manukumar (C7RA13661G-(cit23)/*[position()=1]) 2017
Manukumar (C7RA13661G-(cit24)/*[position()=1]) 2017; 8
Pendleton (C7RA13661G-(cit6)/*[position()=1]) 2013; 11
Chen (C7RA13661G-(cit19)/*[position()=1]) 2017; 8
Ruppe (C7RA13661G-(cit4)/*[position()=1]) 2015; 5
Magiorakos (C7RA13661G-(cit2)/*[position()=1]) 2012; 18
Boucher (C7RA13661G-(cit5)/*[position()=1]) 2009; 48
Wright (C7RA13661G-(cit9)/*[position()=1]) 2005; 57
Archer (C7RA13661G-(cit28)/*[position()=1]) 2011; 2
Andersson (C7RA13661G-(cit25)/*[position()=1]) 2010; 8
References_xml – volume: 2
  start-page: 445
  year: 2011
  ident: C7RA13661G-(cit28)/*[position()=1]
  publication-title: Virulence
  doi: 10.4161/viru.2.5.17724
  contributor:
    fullname: Archer
– volume: 70
  start-page: 267
  year: 2005
  ident: C7RA13661G-(cit13)/*[position()=1]
  publication-title: Biochemistry
  contributor:
    fullname: Lewis
– volume: 8
  start-page: 2181
  issue: 12
  year: 2017
  ident: C7RA13661G-(cit24)/*[position()=1]
  publication-title: MedChemComm
  doi: 10.1039/C7MD00486A
  contributor:
    fullname: Manukumar
– year: 2017
  ident: C7RA13661G-(cit23)/*[position()=1]
  publication-title: Arabian J. Chem.
  doi: 10.1016/j.arabjc.2017.09.017
  contributor:
    fullname: Manukumar
– volume: 27
  start-page: 3148
  year: 2017
  ident: C7RA13661G-(cit31)/*[position()=1]
  publication-title: Bioorg. Med. Chem. Lett.
  doi: 10.1016/j.bmcl.2017.05.032
  contributor:
    fullname: Zha
– volume: 68
  start-page: 1
  year: 2016
  ident: C7RA13661G-(cit16)/*[position()=1]
  publication-title: Bioorg. Chem.
  doi: 10.1016/j.bioorg.2016.07.001
  contributor:
    fullname: Rakesh
– volume: 15
  start-page: 167
  year: 2002
  ident: C7RA13661G-(cit11)/*[position()=1]
  publication-title: Clin. Microbiol. Rev.
  doi: 10.1128/CMR.15.2.167-193.2002
  contributor:
    fullname: Donlan
– volume: 4
  start-page: 25
  year: 2017
  ident: C7RA13661G-(cit27)/*[position()=1]
  publication-title: Medicines
  doi: 10.3390/medicines4020025
  contributor:
    fullname: Mace
– volume: 12
  start-page: 249
  year: 2012
  ident: C7RA13661G-(cit3)/*[position()=1]
  publication-title: Lancet Infect. Dis.
  doi: 10.1016/S1473-3099(11)70316-4
  contributor:
    fullname: Piddock
– volume: 25
  start-page: 469
  year: 2012
  ident: C7RA13661G-(cit29)/*[position()=1]
  publication-title: Food Control
  doi: 10.1016/j.foodcont.2011.11.030
  contributor:
    fullname: Da Silva Meira
– volume: 5
  start-page: 21
  year: 2015
  ident: C7RA13661G-(cit4)/*[position()=1]
  publication-title: Ann. Intensive Care
  doi: 10.1186/s13613-015-0061-0
  contributor:
    fullname: Ruppe
– volume: 6
  start-page: 108315
  year: 2016
  ident: C7RA13661G-(cit15)/*[position()=1]
  publication-title: RSC Adv.
  doi: 10.1039/C6RA23374K
  contributor:
    fullname: Rakesh
– volume: 19
  start-page: 265
  year: 2013
  ident: C7RA13661G-(cit21)/*[position()=1]
  publication-title: Heterocycl. Commun.
  doi: 10.1515/hc-2013-0035
  contributor:
    fullname: Akbar
– volume: 8
  start-page: 260
  year: 2010
  ident: C7RA13661G-(cit25)/*[position()=1]
  publication-title: Nat. Rev. Microbiol.
  doi: 10.1038/nrmicro2319
  contributor:
    fullname: Andersson
– volume: 6
  start-page: 18877
  year: 2016
  ident: C7RA13661G-(cit30)/*[position()=1]
  publication-title: Sci. Rep.
  doi: 10.1038/srep18877
  contributor:
    fullname: Mu
– volume: 8
  start-page: 1173
  year: 2017
  ident: C7RA13661G-(cit18)/*[position()=1]
  publication-title: MedChemComm
  doi: 10.1039/C7MD00111H
  contributor:
    fullname: Wang
– volume: 47
  start-page: 137
  year: 2011
  ident: C7RA13661G-(cit7)/*[position()=1]
  publication-title: Medicina
  doi: 10.3390/medicina47030019
  contributor:
    fullname: Giedraitienė
– volume: 48
  start-page: 1
  year: 2009
  ident: C7RA13661G-(cit5)/*[position()=1]
  publication-title: Clin. Infect. Dis.
  doi: 10.1086/595011
  contributor:
    fullname: Boucher
– volume: 6
  start-page: 254
  year: 2015
  ident: C7RA13661G-(cit20)/*[position()=1]
  publication-title: Eurasian J. Anal. Chem
  contributor:
    fullname: Rakesh
– volume: 68
  start-page: 259
  year: 2015
  ident: C7RA13661G-(cit1)/*[position()=1]
  publication-title: J. Antibiot.
  doi: 10.1038/ja.2014.142
  contributor:
    fullname: Mohammad
– volume: 25
  start-page: 1072
  year: 2015
  ident: C7RA13661G-(cit14)/*[position()=1]
  publication-title: Bioorg. Med. Chem. Lett.
  doi: 10.1016/j.bmcl.2015.01.010
  contributor:
    fullname: Rakesh
– volume: 8
  start-page: 1706
  year: 2017
  ident: C7RA13661G-(cit19)/*[position()=1]
  publication-title: MedChemComm
  doi: 10.1039/C7MD00209B
  contributor:
    fullname: Chen
– volume: 18
  start-page: 268
  year: 2012
  ident: C7RA13661G-(cit2)/*[position()=1]
  publication-title: Clin. Microbiol. Infect.
  doi: 10.1111/j.1469-0691.2011.03570.x
  contributor:
    fullname: Magiorakos
– volume: 57
  start-page: 1451
  year: 2005
  ident: C7RA13661G-(cit9)/*[position()=1]
  publication-title: Adv. Drug Delivery Rev.
  doi: 10.1016/j.addr.2005.04.002
  contributor:
    fullname: Wright
– volume: 11
  start-page: 297
  year: 2013
  ident: C7RA13661G-(cit6)/*[position()=1]
  publication-title: Expert Rev. Anti-Infect. Ther.
  doi: 10.1586/eri.13.12
  contributor:
    fullname: Pendleton
– volume: 358
  start-page: 135
  year: 2001
  ident: C7RA13661G-(cit10)/*[position()=1]
  publication-title: Lancet
  doi: 10.1016/S0140-6736(01)05321-1
  contributor:
    fullname: Stewart
– volume: 156
  start-page: 128
  year: 2011
  ident: C7RA13661G-(cit26)/*[position()=1]
  publication-title: J. Controlled Release
  doi: 10.1016/j.jconrel.2011.07.002
  contributor:
    fullname: Huh
– volume: 12
  start-page: 35
  year: 2014
  ident: C7RA13661G-(cit8)/*[position()=1]
  publication-title: Nat. Rev. Microbiol.
  doi: 10.1038/nrmicro3155
  contributor:
    fullname: Wilson
– volume: 26
  start-page: 1675
  year: 2017
  ident: C7RA13661G-(cit17)/*[position()=1]
  publication-title: Med. Chem. Res.
  doi: 10.1007/s00044-017-1878-x
  contributor:
    fullname: Rakesh
– volume: 7
  start-page: 11414
  year: 2017
  ident: C7RA13661G-(cit22)/*[position()=1]
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-017-11597-z
  contributor:
    fullname: Manukumar
– volume: 8
  start-page: 623
  year: 2010
  ident: C7RA13661G-(cit12)/*[position()=1]
  publication-title: Nat. Rev. Microbiol.
  doi: 10.1038/nrmicro2415
  contributor:
    fullname: Flemming
SSID ssj0000651261
Score 2.440714
Snippet Gram-negative members of the ESCAPE family are more difficult to treat, due to the presence of an additional barrier in the form of a lipopolysaccharide layer...
SourceID pubmedcentral
proquest
crossref
pubmed
SourceType Open Access Repository
Aggregation Database
Index Database
StartPage 5473
SubjectTerms Ampicillin
Antibiotics
Bacteria
Biofilms
Chemistry
Cytoplasm
Efflux
Gram-negative bacteria
Optical density
Optical properties
Survivability
Title Promising bactericidal approach of dihydrazone analogues against bio-film forming Gram-negative bacteria and molecular mechanistic studies
URI https://www.ncbi.nlm.nih.gov/pubmed/35542417
https://www.proquest.com/docview/2010890610/abstract/
https://search.proquest.com/docview/2662549715
https://pubmed.ncbi.nlm.nih.gov/PMC9078102
Volume 8
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1NT9wwEB0BB8qlaukHoRS5aq9mnXUS20e0KqBKVKgqErfIjp0lEklQdjmUn8CvZuysV2x76y2WP2J5nLw39vgZ4FvOuNAqYzRTltOsqKdUMWuodJxjgkmV-4PClz-Li-vsx01-swV5PAsTgvYr05x0d-1J19yG2Mr7tprEOLHJ1eVMeYUaNp1sw7bg_IWLPv5-EcOKNEqRcjWpxKBTjkA034Ndj6-IWmITh_4hl3_HSL4AnbM38HrFFsnp2Ku3sOW6fXg1i5e0vYOnq6HHZ8QfYkbd5aqxWCNKhZO-Jra5_WMH_dh3juhuXKxZED3XDVJDYpqe1s1dSzx79e2cD7qlnZsHRfDYqsaalrTxLl3SOn9iOIg8k8UYivgers--_55d0NX1CrRCFF_SQno24jSCfq1VXQmW2ykSwqySDklOisShRvSq0XnOKiQmtbOZkMYw67gVmeQfYKfDrh8AcZw5nRsZ9PS4kSoTRtRTZO6F1jItEvgaB7u8H1U0yrD7zVU5E79Og3XOEziKdihXX9Ki9Lv1UiHrYAl8WWfjyPqNDd25_gHLFIX3c0WaJ_BxNNv6NdHeCYgNg64LeH3tzRycdkFnezXNDv-75ifYw-7LccXmCHaWw4P7jBxmaY6D738cZu4ze571vQ
link.rule.ids 230,315,733,786,790,870,891,27957,27958,53827,53829
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3PT9swFH5iTBpc2G8IY5un7Zo2iZPYPqJq0G0UoQkmbpEdOyUaSVDaHuBP4K_ec1JXlJ22WyLbiZ1n5_ue_fwZ4EsSUCZFHPix0NSP0yLyRaCVzw2leBNwkdiNwpPTdHwRf79MLjcgcXthuqD9XJWD-roa1OVVF1t5U-VDFyc2PJuMhFWoCaLhE3iK4zViD5z0_geMKJaGToyUimHOWhlShKLpNjyzCIu4xdaR6C96-ThK8gHsHD2HX67CfbTJ78Firgb53SMtx39u0QvYWRJRctgnv4QNU7-CrZE7_-013J-1DV4jtBHVSzrnpcYSToWcNAXR5dWtbuVdUxsi634eaEbkVJbIOokqG78orytiibF9znErK782005s3D1VYklNKndML6mM3Yzc6UeTWR_l-AYujr6ej8b-8uQGP0eCMPdTbomOkcgnCimKnAWJjpBrxjk3yJ9C5CQFAmOBfnmcI-cpjI4ZVyrQhmoWc_oWNmus-h4QQwMjE8U7qT6quIiZYkWETkEqJQ9TDz47K2Y3vUBH1i2sU5GN2M_DzuzHHhw4A2fLQTrLbCAAF0hoAg8-rZLxy9o1E1mbZoF50tS60CxMPNjt-8PqNa4jecDWesoqg5XuXk9B-3cS3kt77_93yY-wNT6fnGQn305_vINtbArvJ4YOYHPeLsx7pEpz9aEbGH8ApCoWyg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB5BkUovvB-BAkZwzebhJLaP1cK2PFqtEJUqLpEd29uIJllldw_0J_CrGSeb1W659ZYotmNnxplv7PE3AB_TkDIpktBPhKZ-ktnYF6FWPjeU4k3IReoOCp-eZSfnydeL9GIr1VcXtF-oclRfVaO6vOxiK-dVEQxxYsH0dCwcQ00YB3Ntg7twD-dsLLYc9f4njJYsiwZCUiqCgrUyomiOZgew76ws2i62a43-g5g3IyW3TM_kIfwaOt1HnPwerZZqVFzf4HO81agewYM1ICVHfZHHcMfUT-D-eMgD9xT-TtsGr9HEEdVTOxelxhoDGzlpLNHl5R_dyuumNkTW_XrQgsiZLBF9ElU2vi2vKuIAsmvnuJWVX5tZRzo-tCqxpibVkK6XVMYdSu54pMmij3Z8BueTzz_HJ_46g4NfIFBY-hl3gMdIxBVWCluwMNUxYs6k4AZxVITYxKKBtOifJwViH2t0wrhSoTZUs4TT57BXY9dfAjE0NDJVvKPso4qLhClmY3QOMil5lHnwYZBkPu-JOvJug52KfMx-HHWiP_bgcBByvp6si9wFBHCBwCb04P3mMX5Zt3cia9OssEyWOVeaRakHL3qd2LxmUCYP2I62bAo4Cu_dJ6gDHZX3Wuavbl3zHexPP03y71_Ovr2GAxwJ79eHDmFv2a7MG0RMS_W2mxv_AEVVGUo
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Promising+bactericidal+approach+of+dihydrazone+analogues+against+bio-film+forming+Gram-negative+bacteria+and+molecular+mechanistic+studies&rft.jtitle=RSC+advances&rft.au=Rakesh%2C+K+P&rft.au=Vivek%2C+H+K&rft.au=Manukumar%2C+H+M&rft.au=Shantharam%2C+C+S&rft.date=2018-01-01&rft.eissn=2046-2069&rft.volume=8&rft.issue=10&rft.spage=5473&rft_id=info:doi/10.1039%2Fc7ra13661g&rft_id=info%3Apmid%2F35542417&rft.externalDocID=35542417
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2046-2069&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2046-2069&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2046-2069&client=summon